Literature DB >> 2844908

Perturbation of beta-glucan receptors on human neutrophils initiates phagocytosis and leukotriene B4 production.

J K Czop1, A V Puglisi, D Z Miorandi, K F Austen.   

Abstract

Normal human neutrophils were stimulated with the yeast cell wall product, zymosan, and examined for two biologic responses, ingestion of particles and production of leukotriene B4 (LTB4), under conditions that were comparable and optimal for the quantitation of each response. Monolayers of adherent neutrophils ingested unopsonized zymosan particles, at particle-to-cell ratios of 12.5:1 to 125:1, in a dose- and time-related manner. At a ratio of 125:1, the percentages of neutrophils ingesting greater than or equal to 1 and greater than or equal to 3 zymosan particles reached plateau levels of 55 +/- 6 and 32 +/- 9% (mean +/- SD, n = 8), respectively, within 30 min. At this same ratio, neutrophils during gravity sedimentation with zymosan particles synthesized LTB4 in a time-dependent manner for at least 45 min. The maximum amount of immunoreactive LTB4 released into supernatants was 3.8 +/- 1.2 ng per 10(6) neutrophils (mean +/- SD, n = 5) and the corresponding total immunoreactive LTB4 was 6.2 +/- 1.9 ng per 10(6) neutrophils. Treatment of 2 x 10(7) suspended neutrophils with 250 micrograms of trypsin for 20 min before concurrent assessment of neutrophil phagocytosis and LTB4 production reduced both of these responses by about 50%. Pretreatment of neutrophils with 800 micrograms/ml of soluble yeast beta-glucan inhibited their ingestion of zymosan by 84% (mean +/- SD, n = 3), with 50% inhibition occurring with 100 micrograms/ml of soluble beta-glucan; 800 micrograms/ml of soluble yeast alpha-mannan had no inhibitory effect. Pretreatment of neutrophils with 400 micrograms/ml of soluble yeast beta-glucan inhibited neutrophil synthesis of LTB4 by 90%, with 50% occurring with 200 micrograms/ml; 400 micrograms/ml of soluble yeast alpha-mannan had no inhibitory effect. The presence of 1.25 micrograms/ml of cytochalasin B during incubation with zymosan particles reduced neutrophil phagocytosis from 65 to 6%, and neutrophil synthesis of LTB4 from total levels of 6.0 +/- 0.3 ng/10(6) cells to zero (mean +/- SD, n = 3). Pretreatment with either cytochalasin B or vinblastine did not alter neutrophil generation of LTB4 induced by calcium ionophore. Neutrophils pretreated with vinblastine, at 4 x 10(-6) to 4 x 10(-4) M, and then maintained at one-half these concentrations during incubation with unopsonized zymosan particles exhibited no diminution in particle ingestion, but were markedly reduced in zymosan-induced synthesis of LTB4.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844908

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Bovine neutrophils recruited by endotoxin to a teat cistern continuously produce oxygen radicals and show increased phagocytosis and extracellular chemiluminescence.

Authors:  C H Sandgren; I Larsson; K Persson
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

2.  An unsuitable and degraded diet? Part three: Victorian consumption patterns and their health benefits.

Authors:  Judith Rowbotham; Paul Clayton
Journal:  J R Soc Med       Date:  2008-09       Impact factor: 5.344

3.  Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan.

Authors:  J Soltys; M T Quinn
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system.

Authors:  Y Ara; T Saito; T Takagi; E Hagiwara; Y Miyagi; M Sugiyama; S Kawamoto; N Ishii; T Yoshida; D Hanashi; T Koshino; H Okada; K Okuda
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

5.  Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production.

Authors:  Hong Lin; Sandy W Y Cheung; Mirjana Nesin; Barrie R Cassileth; Susanna Cunningham-Rundles
Journal:  Clin Vaccine Immunol       Date:  2006-11-08

6.  Glucan receptor and zymosan-induced lysosomal enzyme secretion in macrophages.

Authors:  H Tapper; R Sundler
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

7.  Beneficial effects of troglitazone on neutrophil dysfunction in multiple low-dose streptozotocin-induced diabetic mice.

Authors:  Y Kannan; M Tokunaga; M Moriyama; H Kinoshita; Y Nakamura
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

8.  Intravenous zymosan-A challenge induces an alveolar inflammatory response.

Authors:  R T Sawyer
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

9.  Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.

Authors:  T J Babineau; P Marcello; W Swails; A Kenler; B Bistrian; R A Forse
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

10.  Enhancement of human monocyte beta-glucan receptors by glucocorticoids.

Authors:  J Kay; J K Czop
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.